Nalgesin Mini (Naproxen Sodium)

Naproxen sodium, the active ingredient in Nalgesin Mini, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It is employed to relieve pain, reduce inflammation, and lower fever in adults and adolescents when prescribed. GNH USA supplies Nalgesin Mini as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nalgesin Mini, an NSAID, acts on inflammatory pathways to manage several painful and febrile conditions. - Musculoskeletal pain: provides analgesia and reduces swelling associated with strains, sprains, and arthritis. - Dysmenorrhea: eases menstrual cramps by diminishing uterine prostaglandin production. - Fever: lowers elevated body temperature through central antipyretic action. - Inflammatory disorders: mitigates signs of inflammation such as redness and edema in conditions like tendonitis.

Adverse reactions may range from mild to severe, depending on individual susceptibility and duration of therapy.

Common Side Effects: - Gastrointestinal discomfort: nausea, dyspepsia, or abdominal pain. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Mild skin rash or pruritus. - Elevated blood pressure in some patients.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Renal impairment or acute kidney injury. - Cardiovascular events such as myocardial infarction or stroke. - Severe hypersensitivity reactions, including anaphylaxis. - Hepatotoxicity manifested by jaundice or elevated liver enzymes.

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications. - Assess gastrointestinal risk: consider protective agents in patients with a history of ulcers. - Monitor renal function: avoid prolonged use in those with existing kidney disease. - Use the lowest effective dose: limit exposure to reduce adverse event likelihood. - Avoid in known hypersensitivity to naproxen or other NSAIDs. - Caution in cardiovascular disease: weigh benefits against thrombotic risk. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Naproxen sodium may alter the pharmacokinetics or pharmacodynamics of several medicines, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of serious bleeding. - Lithium: naproxen can raise lithium serum concentrations, risking toxicity. - Methotrexate: reduced clearance may lead to heightened methotrexate toxicity.

Moderate Interactions (Monitor Closely): - Selective serotonin reuptake inhibitors (SSRIs): additive bleeding risk. - Diuretics and antihypertensives: possible reduction in renal perfusion and blood pressure control. - Corticosteroids: enhanced gastrointestinal ulcer risk when combined.